Termination - Request for Adverse Judgment After Institution | Oct 1, 2015 | PAPER | BOARD |
Request for Adverse Judgment | Sep 29, 2015 | PAPER | PETITIONER |
Order - Conduct of the Proceeding - 37 CFR 42.5 | Sep 25, 2015 | PAPER | BOARD |
Patent Owners' Notice of Deposition of Joachim Kalden | Sep 18, 2015 | PAPER | PATENT OWNER |
DECISION Motion for Pro Hac Vice Recognition of Mr. Gindler | Aug 20, 2015 | PAPER | BOARD |
Notice of Stipulation Extending Due Dates 1-4 | Aug 20, 2015 | PAPER | PATENT OWNER |
Decision - Institution of Inter Partes Review 37 C.F.R. 42.108 | Jul 17, 2015 | PAPER | BOARD |
Scheduling Order | Jul 17, 2015 | PAPER | BOARD |
Patent Owners Updated Mandatory Notices Pursuant to 37 C.F.R. 42.8 | May 11, 2015 | PAPER | PATENT OWNER |
Patent Owner's Preliminary Response | Apr 27, 2015 | PAPER | PATENT OWNER |
Patent Owner Exhibit List | Apr 27, 2015 | PAPER | PATENT OWNER |
Z. Chustecka, Rituximab in RA_we should aim for permanent remission_Medscape Medical News (June 16, 2004) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Rituxan Prescribing Information (Feb. 2006) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Notice of Allowance (March 17, 2010) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Office Action (February 7, 2007) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
W. Kelley et al., TEXTBOOK OF RHEUMATOLOGY, Fifth Edition (1997) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
H. J. Williams et al., Comparison of Auranofin, Methotrexate, and the Combination of Both in the Treatment of Rheumatoid Arthritis, Arthritis and Rheumatism, Vol. 35, No. 3 (March 1992) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
R. F. Wilkens et al., Comparison of Azathioprine_Methotrexate_and the Combination of the Two in the Treatment of Rheumatoid Arthritis_Arthritis and Rheumatism | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
L. W. Moreland et al., Double-Blind, Placebo-Controlled Multicenter Trial Using Chimeric Monoclonal Anti-CD4 Antibody, cM-T412, In Rheumatoid Arthritis Patients Receiving Concomitant Methotrexate, Arthritis a Rheumatism, Vol. 38, No. 11, pp 1581-1588 (Nove | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
C. J. Haagsma et al., Combination of Sulphasalazine and Methotrexate Versus the Single Components in Early Rheumatoid Arthritis_A Randomized, Controlled, Double-Blind, 52 Week Clinical Trial, British Journal of Rheumatology, 36_1082-1088 (1997) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
I. L. Dwosh et al., Plasmapheresis Therapy in Rheumatoid Arthritis, The New England Journal of Medicine, Vol 308, No. 18 (May 5, 1983) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
J. Harris and J. Vaughan, Transfusion Studies In Rheumatoid Arthritis, Supplied by The British Library (1958) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
D. Carson, Role of Rheumatoid Factor B Cells in Normal and Pathologic Antigen Presentation, Abstracts Presented at the Fourth International Synovitis Workshop, Dallas, Texas (April 21-25, 1999) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
P.S. Penglis et al., HLA DR4_A Link Between Rheumatoid Arthritis and Cat Exposure, Abstracts Presented at the Annual Scientific Meeting of the Australian Rheumatology Association, Sydney, New South Wales (May 24-27, 1998) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
J. C. W. Edwards et al., B-lymphocyte Depletion Therapy in Rheumatoid Arthritis and Other Autoimmune Disorders, Biochemical Society Transactions, Vol. 30, pt. 4 (2002) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
M. K. Slifka et al., Humoral Immunity Due to Long-Lived Plasma Cells, Immunity, Vol. 8, 363-372 (March 1998) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
R. J. Looney, Update on the Use of Rituximab For Intractable Rheumatoid Arthritis, Open Access Rheumatology Research and Reviews, Dovepress, 2009_1 83-94 (2009) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Declaration by Dr. Ronald F. Van Vollenhoven, in EPO Proceedings for EP 1176981(January 9, 2012 ) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
H. M. Lorenz and J. R. Kalden, Biological Agents in Rheumatoid Arthritis_Which Ones Could Be Used In Combination, BioDrugs, 9 (4)_303-324 (April 1998) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
H. Schulze-Koops and J. R. Kalden, Where Is Biological Therapy Going, Arthritis Res. 2_337-341 (2000) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
J. C. W. Edwards and G. Cambridge, Sustained Improvement In Rheumatoid Arthritis Following A Protocol Designed to Deplete B Lymphocyets, British Society for Rheumatology, 40_205-211 (2001) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Transcript of Proceedings, Department of Health and Human Services, Food and Drug Administration, Center for Biological Evaluation and Research (July 25, 1997) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
T. F. Kresina, IMMUNE MODULATING AGENTS, Marcel Dekker, Inc. (1998) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Form 10-K for Genentech, Inc. (Fiscal Year Ended Dec. 31, 2008 ) | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2008 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2009 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2010 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2011 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2012 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2013 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Finance Report 2014 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Roche Press Release dated July 11, 2006 | Apr 27, 2015 | EXHIBIT | PATENT OWNER |
Unopposed Motion for Pro Hac Vice Admission of David Gindler | Apr 2, 2015 | PAPER | PATENT OWNER |
Patent Owner Power of Attorney and Notice of Appearance of Additional Counsel | Mar 9, 2015 | PAPER | PATENT OWNER |
Errata | Feb 2, 2015 | PAPER | BOARD |
Notice of Filing Date Accorded to Petition | Jan 27, 2015 | PAPER | BOARD |
Expunged | Jan 27, 2015 | PAPER | BOARD |
Related Matters | Jan 16, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Power of Attorney | Dec 15, 2014 | PAPER | PETITIONER |
Power of Attorney | Dec 15, 2014 | PAPER | PETITIONER |
Petition for IPR of 7820161 | Dec 15, 2014 | PAPER | PETITIONER |
Ex 1001 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1002 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1003 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1004 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1005 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1006 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1007 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1008 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1009 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1010 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1011 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1012 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1013 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1014 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1015 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1016 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1017 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1018 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1019 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1020 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1021 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1022 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1023 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1024 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1025 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1026 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1027 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1028 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1029 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1030 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1031 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1032 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1033 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1034 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1035 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1036 | Dec 15, 2014 | EXHIBIT | PETITIONER |